Eden Biodesign and ImmunoBiology (ImmBio) develop next generation vaccine for the prevention of influenza
21-Mar-2007 -
Eden Biodesign Ltd, provider of development and manufacturing services for new medicines, announced that it has been selected by ImmunoBiology Limited (ImmBio), a biotechnology company developing the next generation of anti-infective vaccines, to provide a range of development and manufacturing ...
anti-infectives
biotechnology
clinical trials
+2